Single-Use Technology applications in vaccines manufacturing: From initial risk assessments to implementation and future trends – An end user perspective
Posted on October 17, 2013
By: Marco Restelli, Operations Manager
Novartis
Introduction The move to improve manufacturing efficiency, flexibility, and reduce costs in the biotech industry is focusing on the shift of the manufacturing paradigm from Stainless Steel (SS) operations to Single Use (SU) applications. Recent literature is full of examples of this change of appro...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
current good manufacturing practices (cGMP), disposable facility, Extractables, extractables and leachables, flexible facilities, full disposable facility, Leachables, Novartis, single-use, Single-use technologies, single-use technology, vaccine, vaccine manufacturing, vaccine production
Related Product Videos
ReadyToProcess WAVE™ 25 Bioreactor System - GE Healthcare Life Sciences
Related Products
ReadyToProcess™ WAVE 25 - GE Healthcare Life SciencesUniVessel® SU - Sartorius Stedim
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
